EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting

Dionysis Kampasis, Elisa Uliassi, Maria Laura Bolognesi

Advanced Drug Delivery Reviews · 2025

DOI: 10.1016/j.addr.2025.115621 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2025. Verfasst von Dionysis Kampasis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Circadian Clocks, Polypharmacology, Brain Diseases, Central Nervous System Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circadian rhythm disruption (CRD) is a common feature of several brain disorders. The restoration of circadian clock function and the development of circadian-based therapies may have significant therapeutic implications for brain diseases that extend beyond sleep disorders. However, several challenges persist due to the complexity of circadian interactions with multiple cellular pathways underlying CRD in brain diseases, together with the CNS compartmentalization, including the presence of the blood-brain barrier (BBB). Against these drawbacks, polypharmacology is a promising strategy to potentially provide greater efficacy by targeting multiple components of the CRD network through drug combinations or multi-target-directed ligands. Polypharmacology also offers innovative approaches to brain drug delivery by enhancing BBB penetration of CNS-directed drugs using combinations, co-drugs, and targeted prodrugs. Herein, we review polypharmacological strategies to improve BBB permeability of CNS agents and suggest the exploitation of polypharmacology as a promising new avenue for circadian clock modulation in the treatment of brain disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circadian ClocksPolypharmacologyBrain DiseasesCentral Nervous System AgentsHumansBlood-Brain BarrierAnimalsDrug Delivery SystemsBrainPermeabilityCircadian Rhythm

Stichwörter der Autor:innen

Blood-Brain BarrierBrain Drug DeliveryCircadian ClockCo-drugsDrug CombinationsMulti-Target-Directed LigandsPolypharmacologyTargeted Prodrugs

Substanzen

Central Nervous System Agents

Autor:innen und Institutionen

  • Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna 40126 Bologna, Italy.
  • Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna 40126 Bologna, Italy. Electronic address: elisa.uliassi3@unibo.it.
  • Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna 40126 Bologna, Italy. Electronic address: marialaura.bolognesi@unibo.it.

Förderung

  • European Commission Marie Sklodowska-Curie Actions

Zitieren

APA

Kampasis, D., Uliassi, E., & Bolognesi, M. L. (2025). Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2025.115621

Vancouver

Kampasis D, Uliassi E, Bolognesi ML. Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting. Advanced Drug Delivery Reviews. 2025. doi:10.1016/j.addr.2025.115621

BibTeX
@article{Kampasis2025,
  author = {Kampasis, Dionysis and Uliassi, Elisa and Bolognesi, Maria Laura},
  title = {Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting},
  journal = {Advanced Drug Delivery Reviews},
  year = {2025},
  doi = {10.1016/j.addr.2025.115621}
}
Kostenlos starten →